A sensitive method for simultaneously detecting and discriminating between bovine herpesviruses types 1 and 5 (BHV-1 and BHV-5) was developed using a nested polymerase chain reaction (PCR) technique. Following amplification using type-common primers derived from gC sequences, amplification using typespecific nesting primers produced different-sized bands specific to the corresponding types, as demonstrated by blot hybridization. Less than 0.1 plaque-forming units (PFU) of each virus and 75 fg or less of viral DNA were routinely detected. The PCR technique amplified correct product from 4 BHV-5 isolates and from 48 BHV-1 isolates, all from the United States, and did not amplify heterologous herpesviruses. The PCR technique was more sensitive than virus isolation in detection of BHV-1 or BHV-5 in nasal secretions from experimentally and naturally infected calves, and it detected BHV-1 or BHV-5 in trigeminal ganglia from these calves.
Bovine herpesviruses types 1 and 5 are members of the family Herpesviridae, subfamily Alphaherpesvirinae. Members of this subfamily are recognized for their wide host range, rapid growth rate in culture, ability to lyse infected cells, and ability to establish latency, primarily in sensory nerve ganglia. 31 Bovine herpesvirus type 1 (BHV-1) is a virus agent that causes a number of diseases in cattle throughout the world. This virus affects both the respiratory and genital tracts causing infectious bovine rhinotracheitis (IBR), infectious pustular vulvovaginitis (IPV) in females, balanoposthitis in males, and conjunctivitis. 23, 28 The virus also has the ability to cross the placenta and cause abortion in pregnant cattle. 22 Although BHV-1 has a relatively low mortality rate, it is an important predisposing disease agent in both feeder cattle 28 and breeder cattle. 22 It persists in cattle populations because of its ability to establish latency in the central nervous system.
Early reports suggested that BHV-1 was also involved in meningoencephalitis, particularly in young calves. 1, 17, 21 The virus was thought to be the cause of outbreaks of fatal meningoencephalitis in calves in many parts of the world including Australia, 18, 21 Hungary, 2 Canada, 3, 19 Argentina, 8 Italy, 29 and the United States. 1 However, work on herpesvirus isolates from these outbreaks and others using restriction site mapping, electron microscopy, cross-hybridization, and monoclonal antibodies has determined that this neurovirulent herpesvirus is distinct from other BHV-1 strains (BHV1.1 and BHV1.2). 5, 7, 10, 16 The neurovirulent strain has been redesignated BHV-5. 32 Bovine herpesvirus type 5 is now thought to be the more common, if not the exclusive, herpesvirus involved as the etiologic agent in natural outbreaks of meningoencephalitis. Mortality from this viral infection can be nearly 100%. 8, 17 Although both BHV-1 and BHV-5 are neurotropic viruses, they differ in their ability to cause encephalitis in experimentally infected calves 4 as well as in their prevalence and mortality rates. 28 For this reason, it is important that they be readily distinguishable from one another in a diagnostic setting. The viruses can be distinguished using restriction endonuclease (RE) mapping 13, 16 or by polymerase chain reaction (PCR) followed by RE mapping in a region of the thymidine kinase gene. 15 Monoclonal antibodies against viral glycoproteins can also identify the viruses, but most currently available diagnostic antibody reagents that recognize BHV-1 react equally well with BHV-5. 10 This report describes a nested PCR that distinguishes BHV-1 from BHV-5 in an efficient, accurate manner. The PCR was applicable to the detection of virus sequences in fresh-frozen tissues and in swabs of respiratory secretions, and it was used to demonstrate shedding and latency of both BHV-1 and BHV-5.
Materials and methods
Viruses. Previously characterized isolates of BHV-1 11 and BHV-5 10, 17 were used in the development of PCR. These included BHV-1.1 (Strains Cooper and Los Angeles), a BHV-1.2 (K22), a and 46 additional bovine isolates of BHV-1 (36 respiratory tract isolates, 5 fetal isolates, and 5 semen isolates). b The BHV-1 isolates were previously identified by specific immunofluorescence. The following BHV-5 isolates were used: TX74 (Strain 30326), 17 TX89, 13 OK92, 14 and CA94 (isolate D9402133.) c Viruses were grown in primary cells, as described previously. 11 Other herpesviruses used include BHV-4 (strains 599 and Movar 33/63), a EHV-1, d and PRV (Aujeszky strain). a Virus DNA preparation. Bovine embryonic lung cells growing in 75-cm 2 flasks of MEM-Earles medium supplemented with 10% fetal calf serum, 1% L-Glutamine, 1% HEPES, and 0.5% of an antibiotic antimycotic solution e and nearing 75% confluency were infected with roughly 10 8 plaque forming units (PFU) of either BHV-1 (823-10902) b or BHV-5 (TX89). Cells were collected by centrifugation at 1,500 RPM for 10 min when infections exceeded 80% cytopathic effect. Cell pellets were resuspended in 1.5 ml of 10 mM Tris, 1 mM EDTA, pH 7.5 (TE) containing 0.5% Nonidet P-40 f and allowed to stand at room temperature for 10 min. Thirty microliters of RNAse f (10 mg/ml) was added to each sample. The samples were mixed gently and centrifuged at 3,000 RPM for 10 min, and the chromosomal DNA pellet was removed and discarded. To the remaining supernatants were added 150 l SDS (10%) and 75 l Proteinase K g (10 mg/ml). Samples were incubated at 42 C for 90 min and extracted once with an equal volume of phenol, and DNA was precipitated at Ϫ20 C with 2½ volumes 95% ethanol and 1/10 volume 3 M sodium acetate. Samples were centrifuged at 10,000 RPM for 20 min at 4 C. DNA pellets were washed once with ethanol, air dried, and resuspended in 100 l 10 mM Tris, 0.1 mM EDTA, pH 7.5. DNA concentrations were determined by 260 absorbance and DNA was diluted in H 2 O to appropriate concentrations prior to use in PCR experiments.
Plasmid DNA preparation. The BHV-1 and BHV-5 glycoprotein C (gC) genes were previously cloned 9 and are designated herein as pgC1 and pgC5, respectively. The cloned plasmids were grown in Escherichia coli strain DH5␣, and DNA was purified by a standard alkaline lysis procedure. 27 DNA was resuspended in TE and concentration determined by 260 absorbance. DNA was diluted in H 2 O to 1 ng/l and stored at Ϫ20 C until use in probe preparation experiments.
Diagnostic specimens. Four-to six-month-old seronegative holstein steers were housed in isolation; two each were inoculated with BHV-1 or BHV-5; two additional calves were contact-exposed to BHV-5-inoculated calves starting 1 day after inoculation. Dose of inoculation was 4 ϫ 10 6 TCID 50 for BHV-5 and 10 6 median tissue culture infective doses (TCID 50 ) for BHV-1, divided between the 2 nostrils and administered by aerosolization as described previously. 4 Nasal swabs were collected every other day and processed for quantitative virus isolation as described previously. 12 On day 14 after inoculation, the calves were euthanized and the trigeminal ganglia were aseptically removed. These were either processed immediately for culture or frozen at Ϫ70 C for subsequent analysis by PCR.
Preparation of nasal swabs and tissues for PCR. Nasal swabs were collected as described previously. 12 Frozen sam-ples were thawed and 50 l of each sample were extracted with 1 volume of chloroform/isoamyl alcohol (24:1). A 1: 100 dilution was made in H 2 O and 1 l was used as template in PCR.
Nucleic acids were prepared from tissue for use in PCR. A 3-6 mm cross section of tissue was incubated overnight at 54 C in 500 l TE, 0.5 mg/ml Proteinase K g and 1% SDS. Samples were overlaid with mineral oil to prevent evaporation. Following digestion, samples were frozen at Ϫ70 C, oil was removed, and samples were thawed and vortexed vigorously. Following subsequent equal-volume extraction of samples with phenol and chloroform/isoamyl alcohol (24: 1), nucleic acids were precipitated with 2 volumes ethanol at Ϫ20 C. Precipitates were washed with ethanol, air-dried, and resuspended in 100 l H 2 O. Nucleic acid concentrations were determined by 260 absorbance and 100 ng/l dilutions in H 2 O were made and stored at 4 C until use in PCR.
Preparation of tissues for virus isolation. Virus isolation from trigeminal ganglia was attempted by cocultivation with primary bovine turbinate cells, as described for recovery of pseudorabies virus from trigeminal ganglia of swine. 6 A 2-mm 2 piece of tissue was minced and digested with 0.1% collagenase f and 0.25% trypsin e for 1 hr at 37 C. Cells were washed and resuspended in growth medium containing 5 mM N-N-hexamethylene-bis-acetamide f and added to a preformed cell monolayer in a 25-cm 2 flask. The monolayer was monitored daily for development of cytopathic effect, then passaged once before being considered negative.
Polymerase chain reaction. Both a flanking and a nesting amplification reaction were performed on all samples tested. Flanking primers gCϩ; (5Ј-gcgggggctcgccgagga-3Ј) and gCϪ (5Ј-gggagcgcacggtcaggggc-3Ј) were derived from sequences conserved between BHV-1 and BHV-5. These primers amplify a 653-bp product in BHV-1 and a 589-bp product in BHV-5. Flanking PCR was carried out in a 50 l volume containing 0.75 ϫ PCR Buffer II, h 1.0 mM MgCl 2 , h 0.2 mM dNTPs (0.2 mM each of dATP, dCTP, dGTP, and dTTP), i 0.5 M primers, 6% glycerol, and 1.5 units (U) Taq Polymerase. h . A 44 l mastermix, 0.75 ϫ in buffer and lacking Taq and template, was prepared and aliquoted into reaction tubes. One microliter of appropriate template was added to each reaction tube and the sample was overlaid with 50 l mineral oil. Following an 8-min incubation at 99 C, the temperature was decreased to 90 C while 5 l of 0.75 ϫ buffer containing 1.5 U Taq was added to each reaction. Cycling consisted of 4 cycles of denaturation at 97 C for 1 min, annealing/extension at 75 C for 1 min, followed by 36 cycles of denaturation at 97 C for 1 min, annealing/extension at 73 C for 1 min. After 40 cycles, a final extension proceeded at 72 C for 5 min.
Bovine herpesvirus type 1 nesting primers 1gCϩ (5Јctcgcctccgccctccccgtg-3Ј) and 1gC-(5Ј-aggccgccccccgccgctag-3Ј) were derived from regions of variability between BHV-1 and BHV-5 and were designed to specifically anneal to BHV-1 and amplify a 274-bp product. The BHV-1 nesting amplifications were performed in a 50-l volume containing 0.5 ϫ PCR Buffer II, h 1.25 mM MgCl 2 , h 0.2 mM dNTPs, i 0.2 M primers, 6% glycerol, and 1.5 U Taq. h Reactions were prepared and initiated as described for the flanking reaction. Cycling for the BHV-1 nesting PCR was identical to BHV-5 nesting primers 5gCϩ (5Ј-ttgcccccgccttcgctttcg-3Ј) and 5 gCϪ (5Ј-gcgtccccaagggcgtctcgtc-3Ј) were also derived from regions of variability between BHV-1 and BHV-5, although these primers were designed to specifically anneal to BHV-5 and amplify a 166-bp product. The BHV-5 nesting amplifications were performed in a 50 l volume containing 1 ϫ PCR Buffer II, h 1.25 mM MgCl 2 , h 0.2 mM dNTPs, i 0.6 M primers, 6% glycerol, and 1.5 U Taq. h Reactions were prepared and initiated as described for the flanking reaction. Cycling for the BHV-5 nesting PCR was identical to that for the BHV-1 nesting PCR.
Reaction products were analyzed by agarose gel electrophoresis. Briefly, 25 l reaction product was analyzed on a 1.4% agarose gel (in 0.5 ϫ Tris-Borate-EDTA buffer) and visualized by ethidium bromide staining.
Probe preparation and blot hybridization. Fluorescein-labeled PCR probes were prepared according to manufacturer instructions, j with the following modifications: a 1:1 ratio of fluorescein (FL)-dUTP:dTTP was used in the amplification; cycling parameters were as described above for the nesting PCR reactions, except the polymerase extension step was extended 30 sec to 2 min; 1 ng of plasmid DNAs were used as template. In addition, an unlabeled control amplification reaction was performed in parallel wherein dTTP was added to a final concentration of 200 M and no FL-dUTP was added. One half of this control reaction was examined by agarose gel electrophoresis to confirm that, in the least, the template DNAs and reagents used in the amplification (excluding FL-dUTP) were performing properly. In probe preparation amplifications, templates were not flanked with the conserved primer pair gCϩ/gCϪ. Rather, plasmids pgC1 and pgC5 were directly amplified using primer pairs 1gCϩ/1gCand 5gCϩ/5gC-, respectively. In this way, fluorescein was directly incorporated into either the 274-bp BHV-1 probe or the 166-bp BHV-5 probe. Following amplification, probes (with mineral oil overlay) were stored at Ϫ20 C until use.
PCR reaction products in agarose gels were both capil-lary-transferred to nitrocellulose membranes k in 0.5 M sodium hydroxide, 1.5 M sodium chloride and fixed to membranes according to standard techniques. 27 Membranes were then prehybridized at 64 C for 3-4 hr in ECL hybridization buffer j without probe in a total volume that exceeded 50 l buffer/cm 2 membrane area. Probes were denatured at 99 C for 5 min and added to the hybridization solution at a concentration of 1 l probe/ml hybridization solution. Probe hybridizations proceeded overnight at 64 C. Following probe hybridization, membranes were washed twice at room temperature in 5 ϫ SSC (20 ϫ SSC contains 3 M sodium chloride, 300 mM sodium citrate, pH 7.0), 0.1% sodium dodecyl sulfate (SDS), followed by 3 washes at 64 C in 0.25 ϫ SSC, 0.1% SDS. Membranes were further processed and exposed to X-ray film j according to manufacturer instructions.
Membranes were stripped of probe prior to hybridization with the second probe by 3 washes at 50 C in 0.2 M sodium hydroxide, 0.1% SDS. Membranes were rinsed in 2 ϫ SSC prior to and following probe stripping.
Preparation of tissues for histopathology. Brain tissue for histologic examination was fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (HE).
Results
PCR specificity. Specific detection of BHV-1 or BHV-5 was achieved by using nesting primers derived from sequence variability between BHV-1 and BHV-5 in the 5Ј end of the gC gene ( Fig. 1) . To confirm specificity, 10 3 TCID 50 of BHV-1 or BHV-5 was used as starting template in PCR using conserved primer pair gCϩ/gCϪ. Flanking PCR amplified a 653-bp product from BHV-1 and a 589-bp product from BHV-5 (Fig.  2) . Nesting PCR using primer pair 1gCϩ/1gCϪ amplified a 274-bp product from the BHV-1 generated 653-bp flanking product and no product from the BHV-5-generated 589-bp flanking product. Conversely, nesting PCR using primer pair 5gCϩ/5gCϪ amplified a 166-bp product from the BHV-5-generated 589-bp flanking product and no product from the BHV-1-generated 653-bp flanking product (Fig. 2) . In a similar experiment, no product was detected in either flanking or nesting PCR using 10 3 TCID 50 of PRV, FHV-1, EHV-1, or BHV-4 as starting template (data not shown). For descriptive purposes, BHV-1 PCR indicates that BHV-1-specific nesting primers were used in nesting amplifications following amplification with the conserved primer pair and, similarly, BHV-5 PCR indicates the amplification with BHV-5-specific nesting primers following conserved amplification.
PCR sensitivity. Bovine herpesvirus type 1 PCR detected 75 fg BHV-1 DNA and BHV-5 PCR detected 50 fg BHV-5 DNA. These levels correspond approximately to detection of 495 and 330 genome equivalents of BHV-1 and BHV-5, respectively. Using previously titered virus stocks, BHV-1 PCR detected 0.06 PFU BHV-1 and BHV-5 PCR detected 0.02 PFU BHV-5. Inclusion of nesting PCR with internal primer pairs generated this sensitivity which was 10-100 ϫ greater than the detection limits observed when performing the flanking reaction alone.
Strain detection. At least six BHV-5 isolates are known. These include 2 originally isolated in Texas (TX 74 and TX 89), 1 in California (CA 94), 1 in Oklahoma (OK92), 1 in Australia, and 1 in Argentina. Infected BT cell culture lysates from all but the Australia and Argentina isolates were tested by BHV-5 PCR. All 4 BHV-5 isolates tested generated the expected 166-bp product in BHV-5 PCR (data not shown).
Fourty-eight isolates of BHV-1 were tested by BHV-1 PCR. In all cases, 1 l of a 10-fold dilution (in H 2 O) of an infected cell culture lysate was used as starting template. All isolates generated the expected 274-bp product in BHV-1 PCR (data not shown).
Detection of BHV in nasal swabs. Six seronegative calves were treated as follows: 2 were inoculated intranasally with BHV-1, 2 were inoculated with BHV-5, and 2 remained noninoculated but were housed together with the 2 BHV-5-inoculated calves beginning 1 day after inoculation. Nasal secretions were tested for presence of virus by virus isolation and both BHV-1 and BHV-5 PCR. In most cases, identical results were obtained by PCR and virus isolation. However, BHV-5 was detected by PCR but not by virus isolation in the following cases: day 10 in 1 of 2 BHV-5-inoculated calves; day 10 in one and day 6 in the other noninoculated contact control calf (Fig. 3) .
Detection of BHV in trigeminal ganglia. Nucleic acid samples prepared from the trigeminal ganglia of all calves were tested by BHV-1 and BHV-5 PCR. In addition, BHV-5 was detected by virus isolation in one of the BHV-5-inoculated calves, but was not detected in the contact control calves (Table 1) . BHV-1 was detected by PCR in both BHV-1-inoculated calves, and BHV-5 was detected by PCR in both BHV-5-inoculated calves and in one of the contact control calves. Southern blotting of trigeminal PCR products and sequential hybridization with BHV-1 and BHV-5 probes (or vice versa) was used to confirm the BHV-1 or BHV-5 origin of products ( Fig. 4) .
Clinical signs and histopathology of BHV-5 in the brain. During the course of infection with BHV-5, the calves exhibited no signs of clinical disease. This is consistent with previous observations of infection in calves of this age group (Belknap, unpublished observation) . Calves inoculated with BHV-1 exhibited a typical course of respiratory tract infection. Following necropsy, histopathologic examination of the brain revealed evidence of encephalitis in calves inoculated with BHV-5 and in contact-exposed calves. Cerebral meningeal edema, congested venules, and prominent lymphatics were observed grossly in calf 32. Marked multifocal perivascular cuffing, gliosis, and some neuronal necrosis was observed in the midbrain and/or medulla in all of the BHV-5-infected calves. Calves inoculated with BHV-1 had no evidence of encephalitis on gross or histologic examination. , and noninoculated calves in contact with the BHV-5 calves (panel C) was amplified using conserved primers gCϩ and gCϪ. One microliter of reaction product was then used in BHV-1 and BHV-5 nesting PCR reactions. Agarose gels containing nested reaction products (top portion of panel) were Southern transferred and blots hybridized with a BHV-1-specific probe (middle portion of panel) or BHV-5-specific probe (lower portion of panel). Panel A was hybridized initially with BHV-1 probe, and panels B and C were hybridized initially with BHV-5 probe. Following probe removal, blots were rehybridized with the converse probe. Size differentiation between BHV-1 and BHV-5 products is shown. Ϫ, H 2 O control (i.e., no template DNA added); TE, a DNA preparation with no trigeminal tissue added; ϩ, 75-fg BHV-1 DNA (in BHV-1 nesting reactions) or 500 fg BHV-5 DNA (in BHV-5 nesting reactions); Ladder, 1 kb DNA ladder. The numbered lanes correspond to calf numbers. Occasionally, primer artifacts (primer dimers) were observed as stained material at the bottom of the gels.
Discussion
A PCR protocol was developed that is based on gC sequence variation between BHV-1 and BHV-5 and allows specific detection of BHV-1 and BHV-5. The protocol routinely detected less than 100 fg of purified DNA and less than 0.1 PFU of infected cell lysate. The protocol appropriately detected all BHV-1 and BHV-5 isolates tested and did not detect any herpesvirus tested other than BHV-1 and BHV-5. The PCR protocol was more effective than traditional virus isolation methods for the detection of BHV-5 shedding in experimentally infected and contact control calves. Virus isolation detected BHV-5 in a total of 14 nasal swab samples from these calves, and PCR specifically detected BHV-5 in these same 14 samples and in 3 additional samples. Finally, the PCR protocol specifically detected BHV-1 in trigeminal ganglia from 2 of 2 BHV-1-inoculated calves and specifically detected BHV-5 in trigeminal ganglia from 2 of 2 BHV-5-inoculated calves and 1 of 2 BHV-5 contact control calves.
Detection of BHV-5 in trigeminal ganglia is shown for the first time. The finding that PCR specifically detected BHV-5 in both BHV-5-inoculated calves while virus isolation detected BHV-5 in only one of these represents a pitfall of the latter technique. It has been shown that herpesviruses are not consistently recovered from trigeminal ganglia coculture with susceptible cells, although it has been regarded as the best method to obtain latent virus. 6, 20 Detection of BHV-1 in trigeminal ganglia has been previously demonstrated by virus isolation 20 and by PCR, 36 and the present report confirms this PCR finding. Other studies have demonstrated that BHV-1 establishes latency, that it can then be reactivated on exposure of the animal to stress or immunosuppressive drugs, and that it can be re-excreted without clinical signs and, in this way, transmitted to other susceptible hosts. 30, 33, 34 The PCR detection of BHV-5 in trigeminal tissue from a calf that acquired the infection by natural transmission may suggest that BHV-5 is maintained naturally in cattle populations through the establishment of latency in these tissues. A 1994 study 4 demonstrated that BHV-5 may be reactivated from latency by dexa-methasone and shed in nasal secretions. Given the present observation that BHV-5 did not cause clinical disease in the challenged animals, it may be that BHV-5 is neuroinvasive, but not always neurovirulent. Similarly, colostrum-fed newborn calves became latently infected without neurologic signs. 4 Thus, as with BHV-1, BHV-5 may be maintained latently in cattle herds and spread subclinically through reactivation of the virus from trigeminal ganglia. The PCR protocol described here will allow further investigation of both the potential subclinical transmission of BHV-5 through cattle populations and the presence of BHV-5 in other tissues.
The observation that BHV-5 was detected by PCR in trigeminal ganglia from only 1 of 2 contact controls warrants discussion. The duration of nasal shedding in these 2 control calves differed significantly. BHV-5 was not detected in trigeminal ganglia from the calf that shed on days, 6, 8 and 10, although it was detected in the calf that shed on days 4, 6, 8, 10, and 14. Apparently, the BHV-5 infection in the latter calf was of a significantly more robust nature such that it maintained a larger window of shedding. The possible reasons for the differences in virus shedding may be numerous. Some of these factors may also influence the establishment of latency and, thus, account for our observation.
Cross-protective immunity between BHV-1 and BHV-5 may have implications for infectivity, latency, and transmission of BHV-5. It may be that there is a short window of time in which calves could contract BHV-5 and, perhaps, establish latency. This is related to the fact that antibody responses to BHV-1 crossreact with BHV-5 10 and may provide cross-protective immunity. Following birth, calves may have colostral immunity, provided they are in a vaccinated or exposed herd. When that immunity wanes, calves may be fatally susceptible to BHV-5 infection. At some time, though, calves are either vaccinated against BHV-1 or contract natural BHV-1 infection and, subsequently, gain cross-protective immunity. It is not yet clear whether BHV-5 can spread in the presence of immunity and become latent, as occurs with BHV-1. 25 Bovine herpesvirus type 5 is shed in respiratory tract secretions at levels 10-to 100-fold lower than BHV-1, 4 a fact confirmed in this study. This may affect its spread to animals with cross-protective immunity. The effect of prior immunity and vaccination on BHV-5 latency is under investigation.
Detection of BHV-1 by PCR has been successfully developed for several BHV-1 target sequences: the gB gene, 26, 37 the thymidine kinase gene, 24, 39 the gC gene, 36 and the gD gene. 38 PCR followed by restriction endonuclease digestion has been used successfully to differentiate BHV-1 from BHV-5, 15 and to differentiate ruminant herpesviruses isolated from several species. 26 The present report shows that PCR based on heterologous regions of the gC gene can be used to simultaneously detect and differentiate between closely related ruminant herpesviruses.
Detection of BHV-1 by PCR in clinical specimens such as semen 36, 38, 39 and nasal swabs 37 has proven to be slightly more sensitive and less time-consuming than virus isolation. Consistent with our findings, dilution of the clinical specimen 37 or extraction of the viral DNA from the specimen 36 proved necessary in order to remove inhibitors of the PCR reaction. In contrast, most of these previous studies have utilized Southern blot or dot-blotting of PCR products to realize increases in detection sensitivity. 35, 38, 39 In the present study increased sensitivity over virus isolation was achieved using a second, nested PCR reaction, which simultaneously discriminated between BHV-1 and BHV-5.
